BRCA突变女性微创风险降低手术时隐匿残留卵巢组织的观察
前瞻性研究纳入20例BRCA突变女性行微创风险降低双侧输卵管卵巢切除术,70%同时行子宫切除术,45%为机器人辅助。病理检查发现6例(30%)卵巢组织超出可见卵巢延伸,距离2至14毫米,中位5毫米;其中83%为BRCA2突变。结论认为现行指南推荐切除可见卵巢外至少20毫米组织在该人群中可能足够。
要点
- BRCA突变女性微创风险降低手术中,30%病理发现卵巢组织超出可见卵巢。
- 卵巢间质显微延伸距离2至14毫米,中位5毫米,多数延伸者为BRCA2突变。
- 现行指南推荐切除可见卵巢外至少20毫米组织在该人群中可能足够。
核心结论
- BRCA突变女性行微创风险降低手术时,约三分之一存在卵巢间质显微延伸超出可见卵巢。
- 现行指南推荐切除可见卵巢外至少20毫米组织在该人群中可能足够。
研究设计与样本
- 前瞻性研究纳入20例BRCA突变女性,于2021年10月至2023年期间入组,行微创风险降低双侧输卵管卵巢切除术。
- 标本按Sectioning and Extensively Examining the Fimbriated End方案分析。
主要发现
- 所有患者均行微创手术,70%(n=14)同时行子宫切除术,45%(n=9)为机器人辅助。
- 1例(5%)术后留院过夜,19例(95%)手术当日出院;1例(5%)发生重大并发症并再入院。
- 6例标本(30%)病理检查发现卵巢组织超出可见卵巢;其中左侧1例(17%)、右侧3例(50%)、双侧2例(33%)。
- 卵巢间质显微延伸超出可见卵巢的距离为2至14毫米,中位5毫米。
- 存在卵巢组织显微延伸的患者中,多数(n=5,83%)为BRCA2突变。
关键数值与推荐
- 现行指南推荐切除可见卵巢外至少20毫米组织。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe extension of ovarian tissue beyond visible and National Comprehensive Cancer Network recommended margins among patients with BRCA mutations undergoing minimally invasive risk-reducing salpingo-oophorectomy. METHODS: A prospective study of patients with BRCA mutations who underwent minimally invasive risk-reducing bilateral salpingo-oophorectomy was conducted. Patient enrollment occurred between October 2021 and 2023. Tissue specimens were analyzed according to the Sectioning and Extensively Examining the Fimbriated End protocol. RESULTS: Twenty women with BRCA mutations were prospectively enrolled. All patients underwent minimally invasive surgery with 70% undergoing concurrent hysterectomy (n = 14). Approximately half of these procedures were performed with robotic assistance (n = 9, 45%). One patient was admitted overnight (5%); the other nineteen were discharged on the day of surgery (95%). One patient experienced a major complication and required readmission (5%). Extension of ovarian tissue beyond the visible ovary was noted on pathologic examination of six specimens (30%). In one patient this was observed on the left (17%), in three on the right (50%), and in two bilateral extension (33%) was noted. The distance ovarian stroma extended microscopically beyond the visible ovary was between 2 and 14 mm, with a median of 5 mm. Among patients with microscopic extension of ovarian tissue, the majority (n = 5, 83%) had a BRCA2 mutation. CONCLUSION: In women with BRCA mutations undergoing risk-reducing minimally invasive surgery, approximately one third had microscopic extension of ovarian stroma beyond the visible ovary. Current guidelines which recommend resection of at least 20 mm of tissue beyond the visible ovary are likely adequate in this population.
引用
- Polan RM, Ali-Fehmi R, Grace AK, et al. Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations. Gynecol Oncol. 2024. PMID: 39003959. doi:10.1016/j.ygyno.2024.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。